| 000 | 01448 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513042617.0 | ||
| 264 | 0 | _c19950627 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParan, E | |
| 245 | 0 | 0 |
_aBeta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cFeb 1995 |
||
| 300 |
_a119-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetus _xphysiology |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xadministration & dosage |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aPindolol _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Cardiovascular _xdrug therapy |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 700 | 1 | _aHolzberg, G | |
| 700 | 1 | _aMazor, M | |
| 700 | 1 | _aZmora, E | |
| 700 | 1 | _aInsler, V | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 33 _gno. 2 _gp. 119-23 |
|
| 999 |
_c7756680 _d7756680 |
||